search icon
      blog search icon

      Longeveron Inc. (LGVN) stock Surges Premarket a Day Before Earnings Report - Stocks Telegraph

      By Gule Rukhsar

      Published on

      March 10, 2022

      10:36 AM UTC

      Longeveron Inc. (LGVN) stock Surges Premarket a Day Before Earnings Report - Stocks Telegraph

      On March 10, Longeveron Inc. (LGVN) stock surged by 26.73% in the premarket, at the last check. The company is set to declare its Q4 and fiscal 2021 financial results on March 11, 2022, before the opening of the market. The company will be hosting the earnings conference call tomorrow at 8:20 am, EST during which corporate updates would also be provided.

      Source: Plus500

      In the previous trading session, the stock remained bullish with a gain of 39.72%. The volume of the shares traded during the session was above the average at 2.33 million shares. LGVN closed the session at a price of $7.07 on Wednesday. At the time of writing, the stock was trading at a price of $8.96 per share in the premarket, on Thursday.

      The clinical-stage biotechnology company, Longeveron Inc. was founded in 2014. Currently, the company has a market capitalization of $99.59 million with its 3.98 million shares outstanding.

      What is Happening with LGVN?

      LGVN stock had been in a downtrend since March 02 while there has been no recent news other than investor conference participation and upcoming earnings. The stock continued its downtrend till March 08 as it reached a low of $5.05. The stock reached such a low price after over a hundred days. Thus, the low price attracted investors towards the stock the following day on March 09. It seems investors are taking advantage of the recent low to stock up the shares of LGVN before the upcoming earnings. While it is uncertain what the cards hold for the stock after the company releases 2021 year-end earnings tomorrow, presently it is enjoying good fortune.

      With a year-to-date loss of 41.43%, the start of 2022 has not been fruitful for the stock so far. Last year, LGVN suffered a downtrend of over 16.3%.

      Recent Participations

      Recently, the company participated in the Q1 virtual Investor Summit, the exclusive smallcap and microcap companies event for connecting with investors. The company’s Chief Executive Officer, Geoff Green presented at the summit on March 8, 2022.

      Before this, the company’s management also participated and presented at the Phacilitate’s Advanced Therapies Week from January 25-28, 2022.

      LGVN’s Recent Board Addition

      On February 17, LGVN announced appointing Todd Girolamo to its Board of Directors. Mr. Girolamo is currently serving as the Chief Legal Officer, Vice President of Corporate Development, and Corporate Secretary for Caladrius Biosciences, Inc.

      More From Stocks telegraph